DEVA:IST
Deva Holding AS
၇၈.၁၀ TRY
arrow_downward
-၁.၃၉%(-၁.၁၀) 1D
အောက် ၁၅, GMT+၃ ၁၈:၁၀:၀၀ · TRY
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for DEVA...
Open
၇၈.၁၀ TRY
High
၇၉.၁၀ TRY
Low
၇၇.၀၅ TRY
Mkt. cap
ဋေ ၁.၅၆ ထ
Avg. vol.
၆.၁၃ သိန်း
Volume
၂.၄၆ သိန်း
52-wk high
၁၀၉.၃၀ TRY
52-wk low
၅၇.၅၀ TRY
EPS
-၄.၂၁ TRY
Shares outstanding
၂၀.၀၀ ကုဋေ
No. of employees
၃ ထောင်
Open
၇၈.၁၀ TRY
High
၇၉.၁၀ TRY
Low
၇၇.၀၅ TRY
Mkt. cap
ဋေ ၁.၅၆ ထ
Avg. vol.
၆.၁၃ သိန်း
Volume
၂.၄၆ သိန်း
52-wk high
၁၀၉.၃၀ TRY
52-wk low
၅၇.၅၀ TRY
EPS
-၄.၂၁ TRY
Shares outstanding
၂၀.၀၀ ကုဋေ
No. of employees
၃ ထောင်
News stories
From web sources and news partners
Yahoo Finance Singapore
·
ပြီးခဲ့သည့် ၂၃ မိနစ်
Credo Technology Group Holding (CRDO) Starts New Optical Connectivity Standards Group
MarketBeat
·
ပြီးခဲ့သည့် ၁၀ မိနစ်
SiTime (NASDAQ:SITM) Stock Falls 8.5% - Time to Sell?
The Olympian
·
ပြီးခဲ့သည့် ၁ နာရီ
Nasdaq reports network disruption, US equities data feeds impacted
CNN
·
ပြီးခဲ့သည့် ၆ နာရီ
Global chipmaker sell-off deepens as enthusiasm for AI stocks wobbles
Profile
DEVA Holding A.Ş. is a Turkish pharmaceutical company operating since 1958. Its principal activities include the development, manufacture and marketing of human pharmaceuticals and active pharmaceutical ingredients. The company also operates in veterinary medicines, cologne, medical ampoules and food supplements.
A majority stake in the company was acquired by EastPharma in 2006. DEVA Holding is listed on Borsa Istanbul, and its chairman and chief executive officer is Philipp Haas.
As of 2025, the company had more than 675 products across 15 therapeutic areas. According to IQVIA data cited in its annual report, DEVA ranked third in the Turkish pharmaceutical market by unit sales in 2025, with a market share of 4.5%. Wikipedia
About Deva Holding AS